from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1521/fadD25

LFCtreatmentdescriptionclass of inhibitor

-0.407

Amikacinug/mL Amikacintranslation

-0.647

Cap5-10ug/mL Capreomycintranslation

-2.796

Rox10-50 ug/mL Roxithromycintranslation

0.315

SM2-5 ug/mL Streptomycintranslation

-0.976

Tet5-10 ug/mL Tetracyclinetranslation

0.162

Rif0.2-5ug/mL Rifampicintranscription

0.482

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.125

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.386

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.006

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.256

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.055

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.085

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.274

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.045

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.481

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.244

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.161

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.340

Nigericin50 uM Nigericinrespiration

0.211

TRC10-150 ug/mL Triclosanrespiration

0.890

TRZ10-25 ug/mL Thioridazinerespiration

-0.783

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.436

menadione6-10 ug/mL Menadionerespiration

-0.008

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.120

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.014

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.016

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.080

NRP_1Non-replicating persistence stage 1dosRassociated

-0.138

Amp0.2mg/mL AmpicillincellWall

0.751

Cephalexin20-100 ug/mL CephalexincellWall

0.745

Cerulenin0.32-5 ug/mL CerulenincellWall

0.085

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.343

EMB10-20 ug/mL EthambutolcellWall

0.190

Eta12-40 ug/mL EthionamidecellWall

-0.166

INH0.2-0.4 ug/mL IsoniazidcellWall

0.310

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.574

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.251

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.200

BZA0.12 mg/mL BenzamidearomaticAmides

-0.672

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.271

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.250

H2O24 mM hydrogen peroxideDNAdamaging

-0.227

Levo10 ug/mL LevofloxacinDNAdamaging

-0.221

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.565

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.172

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.256

UVUV-irradiationDNAdamaging

0.137

ARP41-4 ug/mL Antitubercular compound ARP4?

0.524

Antimycin12.5-50 ug/mL Antimycin A?

-1.342

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.584

PA_110-50 ug/mL Antitubercular compound PA-1?

0.605

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.844

PA8240.2-2 ug/mL PA-824?

-0.524

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.080

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.413

Verapamil50 uM Verapamil?

-1.001

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.492

methoxatin10-20 ug/mL Methoxatin?